MYD88 L265P Mutation Is a Possible Unfavorable Prognostic Factor in Patients with Diffuse B-Cell Lymphoma

被引：2
|
作者：
Sidorova, Anna A. [1 ]
Zvonkov, Eugene E. [1 ]
Sudarikov, Andrey B. [1 ]
Severina, Nataliya A. [2 ]
Kovrigina, Alla M. [1 ]
Troitskaya, Vera V. [1 ]
Savchenko, Valeri G. [1 ]
机构：
[1] Natl Res Ctr Hematol, Moscow, Russia
[2] Natl Res Ctr Hematol, Mol Hematol, Moscow, Russia
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.5051.5051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] MYD88 (L265P) MUTATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Fernandez, C.
    Garcia, M.
    Sanchez, B.
    Vela, M. C.
    Pairet, S.
    Camacho, L.
    Gimeno, E.
    Senin, A.
    Besses, C.
    Serrano, S.
    Salar, A.
    Bellosillo, B.
    HAEMATOLOGICA, 2014, 99 : 149 - 149
  • [2] MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma
    C Fernández-Rodríguez
    B Bellosillo
    M García-García
    B Sánchez-González
    E Gimeno
    M C Vela
    S Serrano
    C Besses
    A Salar
    Leukemia, 2014, 28 : 2104 - 2106
  • [3] MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma
    Fernandez-Rodriguez, C.
    Bellosillo, B.
    Garcia-Garcia, M.
    Sanchez-Gonzalez, B.
    Gimeno, E.
    Vela, M. C.
    Serrano, S.
    Besses, C.
    Salar, A.
    LEUKEMIA, 2014, 28 (10) : 2104 - 2106
  • [4] MYD88 expression and L265P mutation in diffuse large B-cell lymphoma
    Choi, Jung-Woo
    Kim, Younghye
    Lee, Ju-Han
    Kim, Young-Sik
    HUMAN PATHOLOGY, 2013, 44 (07) : 1375 - 1381
  • [5] DETECTION OF MYD88 L265P IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Sidorova, A.
    Zvonkov, E.
    Sudarikov, A.
    Severina, N.
    Gabeeva, N.
    Kovrigina, A.
    Troitskaya, V.
    Savchenko, V.
    HAEMATOLOGICA, 2015, 100 : 763 - 764
  • [6] CLINICAL IMPLICATIONS OF MYD88 L265P MUTATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Sidorova, A.
    Zvonkov, E.
    Sudarikov, A.
    Severina, N.
    Gabeeva, N.
    Kovrigina, A.
    Troitskaya, V.
    Savchenko, V.
    HAEMATOLOGICA, 2016, 101 : 816 - 816
  • [7] MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era
    Nishimura, Noriko
    Takeuchi, Kengo
    Asaka, Reimi
    Tuyama, Naoko
    Inoue, Norihito
    Kusano, Yoshiharu
    Mishima, Yuko
    Yokoyama, Masahiro
    Terui, Yasuhito
    LEUKEMIA RESEARCH, 2020, 97
  • [8] Clinicopathologic Significance of MYD88 L265P Mutation in Diffuse Large B-Cell Lymphoma (DLBCL)
    Talaat, Ahmed
    El-Ashwah, Shaimaa
    Tharwat, Layla
    Eladl, Ahmed
    Shamaa, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S430 - S430
  • [9] MYD88 (L265P) Somatic Mutation in Marginal Zone B-cell Lymphoma
    Martinez-Lopez, Azahara
    Curiel-Olmo, Soraya
    Mollejo, Manuela
    Cereceda, Laura
    Martinez, Nerea
    Montes-Moreno, Santiago
    Almaraz, Carmen
    Revert, Jose B.
    Piris, Miguel A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (05) : 644 - 651
  • [10] Expression of MYD88 L265P Mutation in Subtypes of Diffuse Large B-Cell Lymphoma in the Pakistani Population
    Shabir, Muhammad Hamad
    Din, Hafeez Ud
    Mahmood, Rafia
    Shehzad, Umair Aslam
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2025, 33 (01) : 10 - 14
12345